Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.615 EUR | 0.00% | -4.15% | -12.47% |
2023 | Athens Medical C.S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Athens Medical C.S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 126.6 | 86.74 | 183 | 132.3 | 146.6 | 123.2 |
Enterprise Value (EV) 1 | 266.7 | 214.8 | 312.2 | 235.7 | 245.2 | 250.5 |
P/E ratio | 48.2 x | 8.06 x | 24.1 x | 31.6 x | 9.74 x | 18 x |
Yield | - | - | - | - | 4.14% | 2.11% |
Capitalization / Revenue | 0.75 x | 0.47 x | 0.93 x | 0.67 x | 0.65 x | 0.53 x |
EV / Revenue | 1.58 x | 1.18 x | 1.58 x | 1.2 x | 1.09 x | 1.07 x |
EV / EBITDA | 11.5 x | 9.07 x | 12.7 x | 12.8 x | 7.79 x | 9.07 x |
EV / FCF | -33.5 x | 16.5 x | 24.9 x | 37.8 x | 29.3 x | -13.7 x |
FCF Yield | -2.98% | 6.08% | 4.01% | 2.65% | 3.41% | -7.31% |
Price to Book | 2 x | 1.21 x | 2.31 x | 1.59 x | 1.44 x | 1.19 x |
Nbr of stocks (in thousands) | 86,736 | 86,736 | 86,736 | 86,736 | 86,736 | 86,736 |
Reference price 2 | 1.460 | 1.000 | 2.110 | 1.525 | 1.690 | 1.420 |
Announcement Date | 4/30/18 | 4/25/19 | 6/30/20 | 4/29/21 | 4/29/22 | 4/27/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 169.3 | 182.7 | 197.3 | 196.9 | 226 | 233.4 |
EBITDA 1 | 23.23 | 23.69 | 24.67 | 18.39 | 31.48 | 27.64 |
EBIT 1 | 13.98 | 15.94 | 16.4 | 9.689 | 22.73 | 18.28 |
Operating Margin | 8.26% | 8.72% | 8.31% | 4.92% | 10.06% | 7.83% |
Earnings before Tax (EBT) 1 | 5.798 | 9.409 | 10.77 | 5.504 | 15.34 | 10.71 |
Net income 1 | 2.627 | 10.76 | 7.589 | 4.185 | 15.05 | 6.846 |
Net margin | 1.55% | 5.89% | 3.85% | 2.13% | 6.66% | 2.93% |
EPS 2 | 0.0303 | 0.1241 | 0.0875 | 0.0482 | 0.1735 | 0.0789 |
Free Cash Flow 1 | -7.96 | 13.05 | 12.52 | 6.238 | 8.364 | -18.32 |
FCF margin | -4.7% | 7.14% | 6.35% | 3.17% | 3.7% | -7.85% |
FCF Conversion (EBITDA) | - | 55.1% | 50.75% | 33.91% | 26.57% | - |
FCF Conversion (Net income) | - | 121.29% | 164.98% | 149.05% | 55.57% | - |
Dividend per Share | - | - | - | - | 0.0700 | 0.0300 |
Announcement Date | 4/30/18 | 4/25/19 | 6/30/20 | 4/29/21 | 4/29/22 | 4/27/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 140 | 128 | 129 | 103 | 98.7 | 127 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 6.031 x | 5.406 x | 5.237 x | 5.622 x | 3.134 x | 4.609 x |
Free Cash Flow 1 | -7.96 | 13.1 | 12.5 | 6.24 | 8.36 | -18.3 |
ROE (net income / shareholders' equity) | 4.33% | 16% | 10.2% | 5.21% | 12.7% | 6.74% |
ROA (Net income/ Total Assets) | 2.39% | 2.76% | 2.82% | 1.54% | 3.38% | 2.74% |
Assets 1 | 109.8 | 389.4 | 269.4 | 272.2 | 445.6 | 250.1 |
Book Value Per Share 2 | 0.7300 | 0.8300 | 0.9100 | 0.9600 | 1.180 | 1.190 |
Cash Flow per Share 2 | 0.0400 | 0.0500 | 0.0900 | 0.5700 | 0.6000 | 0.1900 |
Capex 1 | 5.83 | 7.96 | 16.3 | 7.08 | 11.3 | 15.9 |
Capex / Sales | 3.45% | 4.36% | 8.25% | 3.59% | 4.99% | 6.8% |
Announcement Date | 4/30/18 | 4/25/19 | 6/30/20 | 4/29/21 | 4/29/22 | 4/27/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-12.47% | 150M | |
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+11.62% | 29.4B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-31.75% | 11.77B | |
-1.42% | 11.72B | |
+27.44% | 11.71B |
- Stock Market
- Equities
- IATR Stock
- Financials Athens Medical C.S.A.